follow us

follow us

Conference Overview

With the augmented incidence of diseases, and the non-medical use of prescription drugs, the incidence of drug abuse has increased enormously in the recent years, which is apparent with the excess documentation of adversities and drug toxicities. In this context, the drug safety and pharmacovigilance has emerged as a dynamic clinical and scientific discipline to provide adequate information and ensure health safety by the joint interaction of doctors and patients in choosing appropriate treatment method and drug. However, evidences suggest though avoidable, the adverse drug reactions (ADRs) to medicines continue to be the bigger life risk. In England, ADR was responsible for up to 6% of hospital admissions, carrying a mortality of 2% and costing the NHS £466 million per annum (€654 million, US$ 602 million) in 2004. In some countries, ADR is ranked among the top 10 leading cause of mortality. The concept of drug safety and pharmacovigilance has evolved considerably and is highly necessary to keep the severity of ADR under check. In order to prevent or to reduce harm to patients and improve public health, it is vital to develop and practice mechanisms for evaluating and monitoring the safety of medicines in clinical use.  Pharmacovigilance brief the potential implications of such trends on the evolution of the science. 

Request Brochure

Sponsors

Media partner

However, these days it is confronting issues to develop a better health care system in this global pitch. Some of the major challenges include globalization, web-based sales and information, broader safety concerns, public health versus pharmaceutical industry economic growth, monitoring of established products, developing and emerging countries, attitudes and perceptions to benefit and harm, outcomes and impact, etc. 

 

The Pharmacovigilance World 2021 conference will provide a platform for the participants to discuss, share and stay updated with present state of affairs in Pharmacovigilance and Drug safety, and how it contributes to the public health. It will also allow all its participants to interact with the experts, discuss the various developments, challenges faced and innovations in the field. Our Pharmacovigilance conferences are known for bringing the world-class leaders together to connect, learn and network. The conference will bring-forth the participants and the representatives from various fields of pharmacovigilance and drug safety under a common umbrella, and will provide them an opportunity to network with various industry professionals including pharmaceuticals, biologics, devices, CROs and PV service providers.

 

It gives us a great pleasure in welcoming you to the Pharmacovigilance World 2021 conference.


Conference Streams Include

 

 

Global PV & Methodologies

Data management & Analytics in PV

PV Automation, AI & Machine Learning

Safety Signals & Management

Pharmacovigilance Regulations

Risk
Management

Patient Centric Drug Safety

Case
Management

Quality &
Compliance

Pharmacovigilance Outsourcing

Medical Devices Safety

Adverse Drug Reactions

 

 

KEY DISCUSSIONS WE'LL BE EXPLORING

  • Pharmacovigilance and globalization
  • Pharmacovigilance in a pandemic world
  • Women and child health care medicines and pharmacovigilance
  • Patient-centric approaches in PV
  • Pharmacovigilance legislation and regulations
  • Harmonization and pharmacovigilance
  • Advanced therapeutic techniques and pharmacovigilance
  • Pharmacovigilance and data management and eudravigilance
  • Post-marketing surveillance in pharmacovigilance
  • PV regulations and challenges
  • Benefit-risk management strategies
  • Risk management and minimization
  • Risk Evaluation and Mitigation
  • Adverse drug reactions reporting
  • Signal detection and post authorization safety
  • Good Pharmacovigilance Practices
  • Innovative approaches to drug safety
  • Strategies to improve PV
  • Real World Evidence in PV
  • Big data and AI in pharmacovigilance
  • Pharmacovigilance Workflows with AI & Automation
  • Other emerging technologies in PV

 

 

WHO SHOULD ATTEND PHARMACOVIGILANCE 2021

 

CEOs, CTOs, CIOs, Presidents, Vice Presidents, Directors, Heads & Managers, Scientific Advisors, Consultants and professionals who work for pharmaceutical, biotechnology & devices industries, CROs and service providers involved in Pharmacovigilance and Drug safety.


Attendees includes Chief Data Officer, VPs, GMs, Directors, Heads and Managers of

  • Pharmacovigilance
  • Safety & Risk management
  • Drug safety
  • PV Compliance
  • Safety Surveillance
  • Medical Affairs
  • Regulatory Affairs
  • Inspection and Audit
  • Pharmacoepidemiology
  • Post-market studies
  • Medical product safety assessment
  • Drug Research & Development
  • Clinical Pharmacology
  • Medical information
  • Contract outsourcing service providers
  • Health outcomes
  • Sales and Marketing

 

 

 

 

pharmaceutical companies

Speakers

VIEW ALL

There are plenty of opportunities to position yourself as a thought leader & showcase your company.

For enquiries on speaker opportunities please e-mail to speaker@corvusglobalevents.com

Become a Speaker


Tuesday - 23rd November 2021 (Time Zone - GMT)

  • 10:00

  • Welcome Address & Platform Orientation - Orientation will focus on how to access and navigate the virtual conference platform for Live Sessions & Interactive Networking

  • 10:20

  • Chairperson’s opening remarks

    Uwe Gudat (Moderator)

    Uwe Gudat (Moderator) Head of Medical Affairs & CSPV
     Fresenius Kabi

  • 10:30

  • Applying a structured approach to benefit-risk assessment and illustrating how it can make a difference in decision making purposes and regulatory approvals of medicinal products

    Stephanie Tcherny

    Stephanie Tcherny Global Head of Benefit-Risk Evaluation
     Sanofi

  • 11:00

  • "X-functional Drug Safety Strategy" - How to set it up and why it is important

    Andreas Osanger

    Andreas Osanger Director - Therapeutic Area Lead Nephrology
     Vifor Pharma

  • 11:20

  • The unmet need for medication adherence

    Mayada Alkhakany

    Mayada Alkhakany Senior Global NTA Manager
     Boehringer Ingelheim

  • 11:40

  • Transforming Safety with End-to-end PV Solutions

    Jen Markey

    Jen Markey Vice President, Safety Strategy, EU
     Veeva Systems

  • 12:00

  • Virtual Luncheon & Networking - Visit Exhibitor Booths & Network with your peers in our Lounge (Face to Face Video Chats)

     

                

  • 12:55

  • Novel AI for Extraction of Adverse Events and Auto Generation of Adverse Event Reports

    Jingqing Zhang

    Jingqing Zhang Head of AI
     Pangaea Data

  • 13:20

  • ICH in Brazil: New PV Regulation following Incorporation of ICH Guidelines

    Raphael Elmadjian Pareschi

    Raphael Elmadjian Pareschi Associate Director Pharmacovigilance
     MSD

Safety Signals and Risk Management

  • 13:40

  • Pivoting Safety to a Strategic Center - with an End-to-end AI Enabled Data Fabric

    • Learn how technology and industry trends are creating opportunity to transform safety to a strategic driver.
    • Gain perspective on how safety systems must evolve to seize this opportunity
    • Hear about ArisGlobal's progress toward enabling the future of pharmacovigilance.
    Beena Wood

    Beena Wood VP, Safety Product Management
     ArisGlobal

  • 14:10

  • Signal Management in Pharmacovigilance – What Is New?

    •  Routine signal detection methods in EudraVigilance
    • Ongoing monitoring activities for signal detection
    • Enhanced quantitative signal detection methods (data mining)
    • Qualitative vs. quantitative assessment of ICSRs
    Dimitris Zampatis

    Dimitris Zampatis Head of Pharmacovigilance EMA- EU/UK QPPV
     Lupin Europe

  • 14:30

  • Implementing a systematic approach in the area of drug safety and risk management

    • Assessment with comprehensive data quality
    • Compliant safety system (GxP compliant, inspection-ready system)
    • Safety signals, effective trials, strategic risk assessment decisions
    Allison Stogdale

    Allison Stogdale Associate Director, Global Patient Safety & Risk Management
     Alnylam Pharmaceuticals

  • 14:50

  • What does a signal, signal?

    Uwe Gudat (Moderator)

    Uwe Gudat (Moderator) Head of Medical Affairs & CSPV
     Fresenius Kabi

  • 15:10

  • Visit Virtual Exhibitor Booths/Speed Networking at our Exclusive Lounge (Face to Face Video chat with Exhibitors and other attendees)

     

         

  • 15:20

  • Fireside Chat: Strengthening Risk Evaluation and Mitigation Strategies (REMS)

    • Creating a REMS Industry-Wide Standardized Risk Evaluation and Mitigation Strategy (REMS) Program
    • Global regulatory developments
    • EU GVP XVI revision – what we could expect?
    • REMS for generics
    • Effective tools and strategies to improve REMS effectiveness
    • REMS at the patient-level: improving safety and proper use of medicines
    • Evolving REMS: New opportunities for branded drugs 
    • What have we learned? Next steps toward the future 
    Uwe Gudat (Moderator)

    Uwe Gudat (Moderator) Head of Medical Affairs & CSPV
     Fresenius Kabi

    Lisa Stagi

    Lisa Stagi Drug Safety & Quality Head
     Roche

    Kal Elhoregy

    Kal Elhoregy Director, Risk Evaluation and Mitigation Strategies
     Amneal Pharmaceuticals

    Lisa Benaise

    Lisa Benaise Vice President, Head of Pharmacovigilance
     Calliditas Therapeutics

    Klaudija Marijanovic Barac

    Klaudija Marijanovic Barac Sr. Director, TPC - Global PSUR & RMP Unit
     Teva Pharmaceuticals

  • 16:00

  • How PV is implemented in MENA

    What do you need to know about the rapidly evolving GVP implementation in the MENA region? Are you keeping the pace to be compliant to local authorities?

    Shahinaz Badr

    Shahinaz Badr Regional Pharmacovigilance Manager
     NewBridge Pharmaceuticals

  • 16:20

  • Post-marketing Signal Detection and management from industrial perspective

    • Sources for identifying safety signals 
    • Present Drug safety signal detection systems and tools and what do they lack 
    • How we can improve the techniques and the tools to have a more efficient signal detection and management 
    Luca Cariolato

    Luca Cariolato Head of Signal Management
     Vifor Pharma

  • 16:40

  • Pharmacovigilance in Mexico: Updates and Challenges

    • Provide the most current Local Regulatory environment in terms of Pharmacovigilance in Mexico
    • Analyze the most important changes within Pharmacovigilance Guidelines
    Rodrigo Ruiz

    Rodrigo Ruiz Head of Country Pharmacovigilance Mexico
     Bristol-Myers Squibb

  • 17:00

  • Panel discussion: PV Outsourcing: Challenges and Opportunities

    • Building partnerships
    • Identifying the key areas for outsourcing
    • The main challenges faced and impact of new legislation
    • Economy
    • PV Quality assurance
    • Post-authorization safety studies
    • Core competencies, activities-database, follow-up studies, case-studies, etc.
    Uwe Gudat (Moderator)

    Uwe Gudat (Moderator) Head of Medical Affairs & CSPV
     Fresenius Kabi

    Joan Francesc Aregall Picamal

    Joan Francesc Aregall Picamal Former Pharmacovigilance Country Head, Spain
     Bayer

    Sharmila Sabaratnam

    Sharmila Sabaratnam Senior Director, Vault Safety Strategy
     Veeva Systems

  • 17:30

  • Chairperson’s closing remarks

    Uwe Gudat (Moderator)

    Uwe Gudat (Moderator) Head of Medical Affairs & CSPV
     Fresenius Kabi

  • 17:40

  • Virtual Networking - Catch-up with your peers in social lounge

     

         

What do the Pass Include


  •  C-Suite keynote sessions & Panel Discussions
  •  Full 2-day live event Access
  •  Interactive live Video chat
  •  Interactive Social lounge with individual tables for discussions & Exchange of Information
  •  Q&A Session and polling
  •  Messaging meetings and networking with Industry Experts and Peers
  •  Access to Virtual expo (including videos, reports and articles from solution providers),
  •  Receiving Handouts
  •  On demand event recordings until 1 month
  •  Certificate for attending

BRING YOUR TEAM
Delegate Registration

Corvus Global Events recognises the value of learning in teams. There's so much great content!!!

Bring your team and get an extra discount. There are special group packages available. Please email to delegate@corvusglobalevents.comfor more details.

register now

PARTNERS

Partnerships typically involve an exchange of value and frequently include online content, PR, advertising, online & event branding.

For enquiries please e-mail to mediapartner@corvusglobalevents.com

Testimonials



Saphetor


As a sponsor and speaker, honestly we couldn't be happier. This is the best value we've had out of a virtual event by a long way. We made connections, got leads, were seen. This was the perfect event for us and one we will definitely plan around. Thank you corvus global events for putting together such a great event.



VIRTUAL PLATFORM

 

Our interactive platform has many rich features and they are a great experience for the users with Networking Video Chat, Polling, Raise Hand, Virtual Exhibitor booths with waiting room/tables, Q&A Sessions with industry experts, virtual chat, Peer to Peer connect at Social Lounge and Handout Bag

 

Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now